1st Quarter - Termination Amendment
BUCHANAN INGERSOLL & ROONEY PC for PHARMACEUTICAL ASSOCIATES, INC.
Income
$10,000
Expenses
—
Terminated
Feb 1, 2021
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Termination | Apr 19, 2021 | $10,000 | Replaced |
| 1st Quarter - Termination Amendment (this page) | May 10, 2021 | $10,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Strategy development and implementation of company's federal government relations initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY COSTA | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK | — |
Medicare/Medicaid MMM
Strategy development and implementation of company's federal government relations initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY COSTA | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK | — |
Pharmacy PHA
Strategy development and implementation of company's federal government relations initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY COSTA | — |
| MICHAEL P STRAZZELLA | — |
| ELIZABETH WESTBROOK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.